Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

October 22, 2018

Primary Completion Date

February 6, 2020

Study Completion Date

November 12, 2020

Conditions
Atopic Dermatitis
Interventions
DRUG

KHK4083

Anti-OX40 Monoclonal Antibody KHK4083

DRUG

Placebo

Matching placebo

Trial Locations (58)

10029

Kyowa Investigational Site US-01, New York

28277

Kyowa Investigational Site US-20, Charlotte

33756

Kyowa Investigational Site US-14, Clearwater

44106

Kyowa Investigational Site US-11, Cleveland

75230

Kyowa Investigational Site US-02, Dallas

77555

Kyowa Investigational Site US-07, Galveston

80010

Kyowa Investigational Site US-10, Aurora

90033

Kyowa Investigational Site US-09, Los Angeles

92647

Kyowa Investigational Site US-19, Huntington Beach

92697

Kyowa Investigational Site US-17, Irvine

92701

Kyowa Investigational Site US-05, Santa Ana

97239

Kyowa Investigational Site US-08, Portland

02115

Kyowa Investigational Site US-04, Boston

Unknown

Kyowa Investigational Site CA-02, Markham

Kyowa Investigational Site CA-03, Richmond Hill

Kyowa Investigational Site CA-08, Richmond Hill

Kyowa Investigational Site CA-07, Québec

Kyowa Investigational Site CA-09, Québec

Kyowa Investigational Site CA-04, Sherbrooke

Kyowa Investigational Site GE-13, Aachen

Kyowa Investigational Site GE-07, Berlin

Kyowa Investigational Site GE-14, Berlin

Kyowa Investigational Site GE-08, Darmstadt

Kyowa Investigational Site GE-05, Frankfurt am Main

Kyowa Investigational Site GE-02, Hamburg

Kyowa Investigational Site GE-11, Hanover

Kyowa Investigational Site GE-01, Langenau

Kyowa Investigational Site JP-17, Aichi

Kyowa Investigational Site JP-27, Aichi

Kyowa Investigational Site JP-24, Chiba

Kyowa Investigational Site JP-08, Fukuoka

Kyowa Investigational Site JP-09, Fukuoka

Kyowa Investigational Site JP-12, Fukuoka

Kyowa Investigational Site JP-19, Fukuoka

Kyowa Investigational Site JP-26, Fukuoka

Kyowa Investigational Site JP-14, Gifu

Kyowa Investigational Site JP-01, Hokkaido

Kyowa Investigational Site JP-02, Hokkaido

Kyowa Investigational Site JP-04, Hokkaido

Kyowa Investigational Site JP-29, Hokkaido

Kyowa Investigational Site JP-31, Ibaraki

Kyowa Investigational Site JP-10, Kagoshima

Kyowa Investigational Site JP-11, Kagoshima

Kyowa Investigational Site JP-05, Kanagawa

Kyowa Investigational Site JP-06, Kanagawa

Kyowa Investigational Site JP-21, Kanagawa

Kyowa Investigational Site JP-18, Mie

Kyowa Investigational Site JP-20, Miyagi

Kyowa Investigational Site JP-28, Morioka

Kyowa Investigational Site JP-25, Shimane

Kyowa Investigational Site JP-15, Tochigi

Kyowa Investigational Site JP-03, Tokyo

Kyowa Investigational Site JP-07, Tokyo

Kyowa Investigational Site JP-13, Tokyo

Kyowa Investigational Site JP-16, Tokyo

Kyowa Investigational Site JP-22, Tokyo

Kyowa Investigational Site JP-23, Tokyo

Kyowa Investigational Site JP-30, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Kyowa Kirin Co., Ltd.

INDUSTRY

lead

Kyowa Kirin, Inc.

INDUSTRY